COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,384 Articles (22,816 medRxiv, 8,568 bioRxiv)

Most recent first Previous |  Page 280: Articles 2791-2800  | Next

Plasma proteomic evidence for increased Alzheimer's disease-related brain pathology after SARS-CoV-2 infection
Duff, E. P., Zetterberg, H., Heslegrave, A., Dehghan, A., Elliott, P., Allen, N., Runz, H., Laban, R., Veleva, E., Whelan, C. D., Sun, B. B., Matthews, P. M.
10.1101/2024.02.02.24302132 — Posted: 2024-02-03
Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses
Gilbert-girard, S., Piret, J., Carbonneau, J., Henaut, M., Goyette, N., Boivin, G.
10.1101/2024.02.02.578538 — Posted: 2024-02-03
Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system
Chervo, T. C., Elkin, E. P., Nugent, J. R., Valice, E., Amsden, L. B., Ergas, I. J., Munneke, J. R., Flores, M., Saelee, G. N., Hsiao, C. A., Schapiro, J. M., Quesenberry, C. P., Corley, D. A., Habel, L. A., Kushi, L. H., Skarbinski, J.
10.1101/2024.01.31.24301674 — Posted: 2024-02-02
Recapitulating memory B cell responses in a Lymphoid Organ-Chip to evaluate mRNA vaccine boosting strategies
Jeger-Madiot, R., Planas, D., Staropoli, I., Kervevan, J., Mary, H., Collina, C., Fonseca, B. F., Debarnot, H., Robinot, R., Gellenoncourt, S., Schwartz, O., Ewart, L., Bscheider, M., Gobaa, S., Chakrabarti, L. A.
10.1101/2024.02.02.578553 — Posted: 2024-02-02
Stratification of viral shedding patterns in saliva of COVID-19 patients
Park, H., Raiki, Y., Iwanami, S., Kim, K., Ejima, K., Nakamura, N., Aihara, K., Miyazaki, Y., Umeyama, T., Miyazawa, K., Morita, T., Watashi, K., Brooke, C. B., Ke, R., Iwami, S., Miyazaki, T.
10.1101/2024.01.30.578034 — Posted: 2024-02-02
LESSONS LEARNED FROM COVID-19 MODELLING EFFORTS FOR POLICY DECISION-MAKING IN LOWER- AND MIDDLE-INCOME COUNTRIES
Owek, C. J., Guleid, F. H., Maluni, J. K., Jepkosgei, J., Were, V., Sim, S. Y., Hutubessy, R., Hagedorn, B. L., Nzinga, J., Oliwa, J. N. N.
10.1101/2024.01.30.24301978 — Posted: 2024-01-31
Real-World Effectiveness of a Third Dose of mRNA-1273 versus BNT162b2 on Inpatient and Medically Attended COVID-19 among Immunocompromised Adults in the United States
Sun, T., Li, L., Mues, K., Georgieva, M., Kirk, B., Mansi, J., Van de Velde, N., Beck, E.
10.1101/2024.01.30.24302015 — Posted: 2024-01-31
The CoLab-score rapidly and efficiently excludes COVID-19 at the emergency department without need for SARS-CoV-2 testing: a multicenter case-control study
Boer, A.-K., Deneer, R., Maas, M., Ammerlaan, H., van Balkom, R. H. H., Leers, M. P., Martens, R. J. H., Buijs, M. M., Kerremans, J. J., Messchaert, M., van Suijlen, J. D. E., van Riel, N. A. W., Scharnhorst, V.
10.1101/2024.01.30.24301996 — Posted: 2024-01-31
Healthy lifestyle for the prevention of post-COVID-19 multisystem sequelae, hospitalization, and death: a prospective cohort study
Wang, Y., Su, B., Alcalde-Herraiz, M., Barclay, N. L., Tian, Y., Li, C., Wareham, N. J., Paredes, R., Xie, J., PRIETO-ALHAMBRA, D.
10.1101/2024.01.30.24302040 — Posted: 2024-01-31
A novel microporous biomaterial vaccine platform for long-lasting antibody mediated immunity against viral infection.
Mayer, D. P., Nelson, M., Andriyanova, D., Antao, O. Q., Chen, J. S., Scumpia, P. O., Weaver, W. M., Deshayes, S., Weinstein, J. S.
10.1101/2024.01.30.578038 — Posted: 2024-01-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).